S&P 500

5.969,34

0,35%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
Canadá
TSX
Aptose Biosciences Inc (APS)
Aptose Biosciences Inc (APS) Notícias

APS

Aptose Biosciences (APS)

Aptose Biosciences Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:TSX:APS

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
27/04/2020	12:02	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - APS	TSX:APS	Aptose Biosciences Inc
27/04/2020	12:00	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - APS	TSX:APS	Aptose Biosciences Inc
27/04/2020	11:59	PR Newswire (Canada)	IIROC Trade Resumption - APS	TSX:APS	Aptose Biosciences Inc
27/04/2020	11:58	PR Newswire (Canada)	IIROC Trading Halt - APS	TSX:APS	Aptose Biosciences Inc
10/06/2015	18:00	PR Newswire (US)	Aptose Biosciences announces results of annual and special meeting of shareholders	TSX:APS	Aptose Biosciences Inc
02/06/2015	15:00	PR Newswire (US)	Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia	TSX:APS	Aptose Biosciences Inc
05/05/2015	17:15	PR Newswire (US)	Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015	TSX:APS	Aptose Biosciences Inc
30/04/2015	09:00	PR Newswire (US)	Aptose Biosciences To Host First Quarter Ended March 31, 2015 Financial Results Conference Call and Webcast	TSX:APS	Aptose Biosciences Inc
23/03/2015	09:30	PR Newswire (US)	Aptose Biosciences Announces Appointment of Dr. Michael Andreeff to Scientific Advisory Board	TSX:APS	Aptose Biosciences Inc
23/03/2015	09:00	PR Newswire (US)	Aptose Biosciences to Present at the 12th Annual BIO Asia International Conference	TSX:APS	Aptose Biosciences Inc
05/03/2015	10:00	PR Newswire (Canada)	Aptose Biosciences to Present at the 27th Annual ROTH Conference	TSX:APS	Aptose Biosciences Inc
03/03/2015	18:30	PR Newswire (US)	Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014	TSX:APS	Aptose Biosciences Inc
26/02/2015	10:00	PR Newswire (US)	Aptose Biosciences To Host Quarter and Seven Month Transition Period Ended December 31, 2014 Conference Call and Webcast	TSX:APS	Aptose Biosciences Inc
25/02/2015	18:39	PR Newswire (US)	Aptose Biosciences to Present at the Cowen & Company 35th Annual Healthcare Conference	TSX:APS	Aptose Biosciences Inc
19/02/2015	11:00	PR Newswire (Canada)	Aptose Biosciences to Present at the RBC Capital Markets 2015 Global Healthcare Conference	TSX:APS	Aptose Biosciences Inc
20/01/2015	20:02	PR Newswire (US)	Aptose Biosciences Appoints Dr. Bradley Thompson to the Audit Committee	TSX:APS	Aptose Biosciences Inc
13/01/2015	21:45	PR Newswire (US)	Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Maligna...	TSX:APS	Aptose Biosciences Inc
12/01/2015	11:00	PR Newswire (Canada)	Aptose Biosciences to Present at Biotech Showcase™ 2015	TSX:APS	Aptose Biosciences Inc
15/12/2014	11:00	PR Newswire (Canada)	Aptose Biosciences Announces Appointment of Dr. Erich Platzer to Board of Directors	TSX:APS	Aptose Biosciences Inc
09/12/2014	11:00	PR Newswire (US)	Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual Meeting	TSX:APS	Aptose Biosciences Inc
05/12/2014	11:00	PR Newswire (US)	Aptose Biosciences to Present at Oppenheimer & Co. 25th Annual Healthcare Conference	TSX:APS	Aptose Biosciences Inc
03/12/2014	11:00	PR Newswire (US)	Aptose Biosciences to Present Preclinical Research Update for APTO-253 at the 56th American Society of Hematology Annual Meet...	TSX:APS	Aptose Biosciences Inc
17/11/2014	11:00	PR Newswire (US)	Aptose Biosciences to Present at The Stifel 2014 Healthcare Conference	TSX:APS	Aptose Biosciences Inc
04/11/2014	19:00	PR Newswire (US)	Aptose Biosciences reports results for the four months ended September 30, 2014	TSX:APS	Aptose Biosciences Inc
30/10/2014	09:01	PR Newswire (US)	Aptose Biosciences To Host Conference Call and Webcast For Four Month Interim Period Ended September 30, 2014	TSX:APS	Aptose Biosciences Inc
21/10/2014	10:00	PR Newswire (US)	Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO	TSX:APS	Aptose Biosciences Inc
03/10/2014	08:00	PR Newswire (US)	Aptose Biosciences to Present at the 2014 BIO Investor Forum	TSX:APS	Aptose Biosciences Inc
01/10/2014	18:16	PR Newswire (US)	Aptose Biosciences Announces Reverse Stock Split	TSX:APS	Aptose Biosciences Inc
29/09/2014	09:30	PR Newswire (US)	Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S...	TSX:APS	Aptose Biosciences Inc
25/09/2014	10:48	PR Newswire (US)	Aptose Biosciences to Present at Upcoming Investor Conferences	TSX:APS	Aptose Biosciences Inc